Health Management

Innovative PBM performance-based pharmacy networks focus on reducing costs and Improving clinical outcomes

What if your healthcare organization could not only create a plan to retain more millennials as employees, but could hook them before they even graduate from school? Here’s how one healthcare system is doing it.

Ochsner Health System’s brings early-stage clinical trials to the Gulf South region.

New cancer developments and research can be challenging to sort through. Here are four misconceptions about cancer that you should know.

In the managed healthcare market, words like logical, predictable, or stable are seldom used anymore. Instead, for healthcare executives, disruption is the norm.

As payers work to avoid costly readmissions, some organizations are experiencing great success by leveraging virtual care communication platforms.

A stepwise approach can be best. Here are seven rules to follow.

A Mayo Clinic study has surprising findings about how controlled substance agreements impact patients on long-term opioid therapy.

An Avalere analysis finds that this factor plays an important role in the era of value-based payment. Find out what it is.

A new Swedish study examined gender differences in rheumatism and other autoimmune diseases. Here are the surprising findings.

A new study has surprising findings about traumatic or stressful life events and the link to developing an autoimmune disease.

Executives from diagnostics, payer, pharma, and patient care companies recently got together to share stakeholder insights on outcomes-based contracting.

Healthcare organizations can improve care and lower costs-across the board-by paying careful attention to the public health issues affecting their communities.

The right strategies can help healthcare organizations go beyond awareness and actively fight stigma when it comes to mental health conditions.

Here’s what’s shaking up the drug launch pricing space. Experts weigh in.

Managed Healthcare Executive asked experts to identify Trump’s top priorities within the plan, and how those priorities could affect managed care.

Managed Healthcare Executive asked experts to weigh in on Trump’s new blueprint to tackle drug market challenges. Here’s what they said.

According to research-backed statistics, telepsychiatry improves the behavioral health outlook for today’s veterans.

Home-based palliative care helps ACOs manage fast-growing senior population with a serious or advanced illness, provide quality care, and generate cost savings that enable ongoing participation in the Medicare Shared Savings Program.

FDA issued a recall of popular blood pressure drugs. Here’s what you need to know.

A new HealthMine survey of Medicare beneficiaries has surprising results about this population’s digital health literacy.

Payers are becoming more receptive to a different approach for paying for addiction treatment and recovery services, as evidenced by the formation of a new healthcare alliance that aims to redesign the structure and payment of these services.

If all consumers had a high understanding of how to navigate the healthcare system, health insurers could save billions of dollars a year. Here’s what you should do.

Here’s how healthcare can do more to help patients learn more about their health to better prepare them to participate in their own treatment.

Glucose monitoring technology could become the go-to management strategy in a few years. Here’s where we are and where we are going.

Here are 4 key ways healthcare executives can leverage community resources to strengthen the availability of tools that support recovery from opioid addiction.

Payers struggle to determine the appropriate criteria for covering innovative treatments and providers want to increase patient access. Patients’ lives can hang in the balance.

A South Korean study may contribute to the improvement of personalized therapeutic outcomes for rheumatoid arthritis by expanding the scope of molecular imaging.

NORC at the University of Chicago set out to understand more Americans’ experiences with surprise billing. You won’t believe what they found.

A new study on the overlap between the causes of rheumatoid arthritis and Huntington’s disease opens up new therapeutic targets and drugs for both conditions.